Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Complications of Intravenous Immune Globulin Treatment in Neurologic Disease
Neurol 47:674-677, Brannagan III,T.H.,et al, 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
Effect of Oestrogen During Menopause on Risk and Age at Onset of Alzheimer's Disease
Lancet 348:429-432, 4201996., Tang,M.X.,et al, 1996
Ketorolac vs Chlorpromazine in the Treatment of Acute Migraine Without Aura
Arch Int Med 156:1725-1728, Shrestha,M.,et al, 1996
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996
Intranasal Lidocaine for Treatment of Migraine:A Randomized, Double-Blind, Controlled Trial
JAMA 276:319-321, Maizels,M.,et al, 1996
Seven-Year Follow-up of Neurologic Involvement in Behcet Syndrome
Arch Neurol 53:691-694, Akman-Demir,G.,et al, 1996
Dose-Ranging Study of Riluzole in Amyotrophic Lateral Sclerosis
Lancet 347:1425-1431, Lacomblez,L.,et al, 1996
Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996
Brain Metastases from an Unknown Primary Tumour:Which Diagnostic Procedures are Indicated
JNNP 61:321-323, van de Pol,M.,et al, 1996
Prophylactic Cranial Irradiation for Small-Cell Lung Cancer
Lancet 348:350, Smith,I.E., 1996
Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996
Treatment of Trigeminal Neuralgia (Editorial)
NEJM 334:1125-1126, Fields,H.L., 1996
Gabapentin as a Novel Treatment for Postherpetic Neuralgia
Neurol 46:1175-1176, Segal,A.&Rordorf,G., 1996
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
Prevention of Brain Haemorrhage and Ischaemic Injury in Premature Babies
Lancet 348:208-209, Koppe,J.G., 1996
Antenatal Phenobarbital Therapy and Neonatal Outcome I:Effect on Intracranial Hemorrhage
Pediatrics 97:644-648, Shankaran,S.,et al, 1996
Three-Dimensional CT Angiography in the Detection and Characterization of Intracranial Berry Aneurysms
AJNR 17:439-445, Hope,J.K.A.,et al, 1996
Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly People
Stroke 27:1274-1282, 12691996., Longstreth,W.T.,et al, 1996
A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Discontinuation of Antiepileptic Drug Treatment after Two Seizure-Free Yrs in Children with Cerebral Palsy
Pediatr 97:192-197, Delgado,M.R.,et al, 1996
Long-term Prognosis in Cerebral Venous Thrombosis:Follow-up of 77 Patients
Stroke 27:243-246, Preter,M.,et al, 1996
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV:A Summary
Ann Int Med 124:349-361, 3421996., , 1996
Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996
Differential Effect of Aspirin Vs Warfarin on Clinical Stroke Types in Pts with Atrial Fibrillation
Neurol 46:238-240, Miller,V.T.,et al, 1996
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Fish Consumption and Stroke in Men
Stroke 27:204-209, Orencia,A.J.,et al, 1996
Lubeluzole in Acute Ischemic Stroke:A Double-Blind Placebo-Controlled Phase II Trial
Stroke 27:76-81, Diener,H.C.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996
Acute Low Back Pain:A New Paradigm for Management
BMJ 313:1343-1344, Deyo,R.A., 1996
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
Long Term Use of Lamotrigine & Vigabatrin in Severe Refractory Epilepsy:Audit of Outcome
BMJ 313:1184-1185, 11571996., Walker,M.C.,et al, 1996
Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996
Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996
Early Treatment of a Single Generalized Tonic-Clonic Seizure to Prevent Recurrence
Arch Neurol 53:1149-1152, Gilad,R.,et al, 1996
Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
Routine Indomethacin Prophylaxis:Has the Time Come
Pediatrics 98:784-785, Bada,H.S., 1996
Prenatal Magnesium Sulfate Expos/Risk for CP or MR Among Very Low-Birth-Weight Child Aged 3-5 Yrs
JAMA 276:1805-1810, 18431996., Schendel,D.E.,et al, 1996
Stimulus-Evoked Sinus Arrest in Severe Guillain-Barre Syndrome:A Case Report
Neurol 47:1239-1242, Minahan,R.E.,et al, 1996
Acute Treatment of Migraine with Dihydroergotamine Nasal Spray
Arch Neurol 53:1285-1291, Gallagher,R.M., 1996
Thunderclap Headache as First Symptom of Cerebral Venous Sinus Thrombosis
Lancet 348:1623-1625, deBruijn,S.F.T.M.,et al, 1996
Vagus Nerve Stimulation for the Treatment of Medically Intractable Seizures
Arch Neurol 53:1176-1180, Salinsky,M.C.,et al, 1996
Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996
Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory partial Epilepsy Using 200-, 400-, and 600-mg Daily Dosages
Neurol 46:1684-1690, Faught,E.,et al, 1996